In one paragraphArticle in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Rebeca P F RochaBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.ORCID 0000-0002-5678-4006 Marina A FontouraBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.ORCID 0000-0002-1192-7210 Fabrício NaciukBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.ORCID 0000-0001-9176-8821 Leonardo C OliveiraBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.
Alice NagaiBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.ORCID 0000-0002-1267-4569 Amanda Bellini SilvaBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.ORCID 0000-0002-8956-3103 Alexandre BorinBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.
Jaqueline S FelipeBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.
Marjorie BruderBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.ORCID 0000-0003-4236-848X Lais D CoimbraBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.
Rafael Elias MarquesBrazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP 13083-100, Brazil.ORCID 0000-0002-6949-0947 Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/10990-1, 2021/05519-0, 2018/02594-9, 2019/0645, 2022/02278-5, 2022/01379-2Ministry of Science, Technology and Innovation PCVENational Council for Scientific and Technological Development Research fellow for REM, INCT-One, INCT-DenguePew Charitable Trusts Scholarship for RPFR
6 · The paper itselfAbstract
Usutu virus (USUV) is an emerging arbovirus recently associated with outbreaks in Western Europe. Although USUV is typically associated with asymptomatic or nonspecific febrile disease, the occurrence of severe neuroinvasive forms of disease has raised concern. There is currently no antiviral treatment available for USUV infection; therefore, we sought to investigate the protective effects of the nucleoside analogue 7DMA against USUV. Adding to 7DMA's activity against USUV in vitro reported by us and others, we found that 7DMA inhibits USUV replication at multiple stages in mammalian cell lines Vero CCL81 and SH-SY5Y. In vivo testing of 7DMA using the susceptible IFNAR
Indexed as
AdenosineAntiviral AgentsFlavivirusFlavivirus InfectionsImmunologic FactorsTubercidinAnimalsChlorocebus aethiopsDisease Models, AnimalFemaleHumansMiceMice, Inbred C57BLMice, KnockoutReceptor, Interferon alpha-betaVero CellsAdenosineAntiviral AgentsImmunologic FactorsReceptor, Interferon alpha-betaTubercidin7DMAantiviralimmunopathogenesismouse modelUsutu virus
Identifiers
PMID41472308
PMCPMC12737359
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390